BARCELONA, Spain I March 07, 2022 I La Merie Publishing released today its newest report entitled “Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing”. This report describes and analyzes the field of Targeted Protein Degradation (TPD) from...
Targeted Protein Degradation (TPD) is emerging as a key technology to overcome limitations of conventional drug modalities and unlock the undrugged proteome
BARCELONA, Spain I March 07, 2022 I La Merie Publishing announced today the launch of the 2nd edition of its report about targeted protein degradation. The report “Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing” describes and...
Prodrug antibodies and cytokines generated by masking technologies provide plenty of opportunities for founders, investors and partnerships
BARCELONA, Spain I October 06, 2021 I La Merie Publishing announced the release of its newest report about antibody and cytokine prodrugs . The report “Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective” provides a landscape description and...
Masked Antibodies and Cytokines as Prodrugs: strongly emerging novel technologies providing plenty of opportunities for founders, investors and partnerships
BARCELONA, Spain I October 06, 2021 I La Merie Publishing announced the release of its newest report about antibody and cytokine prodrugs . The report “Masked Antibodies & Cytokines As Prodrugs: a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective” provides a landscape description and...
Vectorized Antibodies for In Vivo Expression by DNA and mRNA: an emerging new technology
BARCELONA, Spain I July 1, 2021 I La Merie Publishing announced the release of its newest report about in vivo delivery of nucleic acid-encoded antibodies . The report “Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an...
Landscape Analysis of Targeted Protein Degradation by Novel PROTACs and Molecular Glues
BARCELONA, Spain I May 14, 2020 I La Merie Publishing announced the release of its newest report about Targeted Protein Degradation. The report “Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective” provides a landscape...
The growing field of bispecific T-cell and NK cell engaging antibodies offers great opportunities for technology and product development companies
June 11, 2019 I We just released a new report describing and analyzing the field of bispecific antibodies used to redirect T-cells or natural killer (NK) cells to tumor cells. Since our first report about this subject three years ago, this specific field of biopharmaceutical research has grown enormously as...
Biologics sales reach another all time high in 2018 driven by innovative antibodies
April 4, 2018 I We just concluded our annual compilation and analysis of sales of recombinant therapeutic antibodies and proteins for the year 2018. The results show another all time high of global sales of more than US$ 202 mln, a plus of 7.3% compared with the previous year. The...
Further record year of biologics sales in 2018 due to innovative antibodies
STUTTGART, Germany I April 4, 2018 I 2018 was another record year for global sales of branded recombinant therapeutic antibodies and proteins: US$ 202 mln (+7.3% vs previous year). Major contributing factor to the growth were sales of therapeutic antibodies which showed a continuous annual growth rate (CAGR) of 14.1%...
Analysis and ranking of TOP 25 pharma-based healthcare groups by business segment for revenues, sales, R&D costs and income
January 16, 2019 I We just released a management report for free download (see our menu „FREE reports“) in which we analyzed key financial data from the TOP 25 pharma-based health care companies with revenues of more than US$ 10 bln in the fiscal year 2017. The report entitled „TOP...